Skip Prichard
JULY 22, 2019
Being the founder of an innovative product or service requires holistic thinking, taking into account all aspects of what makes a new venture successful—from its value proposition to the customer (user), product development, technologies, cost to deliver, performance metrics and finally to getting the resources needed for implementation.
Harvard Business Review
FEBRUARY 16, 2016
Aside from these three broad worries, directors are also anxious about corporate tax rates, political instability, and healthcare costs. Not surprisingly, with the price of oil dropping, directors of companies the energy & utilities industries are particularly discouraged. Why does all this matter?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Harvard Business Review
JUNE 21, 2013
If, in addition, companies are managing their underperformers out poorly, the costs rise even further. food, beverage & tobacco, household and personal products); Energy & Utilities (e.g., pharmaceuticals, biotechnology & life sciences, health care equipment and services); Industrials (e.g.,
Harvard Business Review
MARCH 28, 2012
But acquisitions, unlike homegrown innovation, don't afford the luxury of multiple low-cost experiments — the sunk costs of an acquisition are too great. In pharma, Johnson & Johnson's 1999 acquisition of Centocor brought in blockbuster biotechnology innovations led by rheumatoid arthritis drug Remicade.
Harvard Business Review
FEBRUARY 22, 2017
food, beverage & tobacco, household and personal products); Energy & Utilities (e.g., pharmaceuticals, biotechnology & life sciences, health care equipment and services); Industrials (e.g., An IBM study estimated that the average cost of a data breach is around $4 million. ” A Real Strategic Threat.
Harvard Business Review
OCTOBER 23, 2014
Energy, agriculture, insurance, retail, human resources — no industry is unaffected. That’s why pharmaceutical, biotechnology, and medical device companies need to define their relevance in this new health care ecosystem, and soon. Or lenders’ enhanced abilities to gauge credit risk. They’re also sharing risk. But not for long.
Harvard Business Review
SEPTEMBER 14, 2011
Chirotech specializes in biocatalysis and chemocatalysis, two important subspecialties of biotechnology and chemistry that help develop key biological and chemical intermediates needed for the efficient production of medicines. are aimed at finding ways to lower the cost of its core activities like software testing.
Expert insights. Personalized for you.
80 
Let's personalize your content